The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation
Open accessAbstract
Exosomes are attractive as nucleic-acid carriers because of their favourable pharmacokinetic and immunological properties and their ability to penetrate physiological barriers that are impermeable to synthetic drug-delivery vehicles. However, inserting exogenous nucleic acids, especially large messenger RNAs, into cell-secreted exosomes leads to low yields. Here we report a cellular-nanoporation method for the production of large quantities of exosomes containing therapeutic mRNAs and targeting peptides. We transfected various source cells with plasmid DNAs and stimulated the cells with a focal and transient electrical stimulus that promotes the release of exosomes carrying transcribed mRNAs and targeting peptides. Compared with bulk electroporation and other exosome-production strategies, cellular nanoporation produced up to 50-fold more exosomes and a more than 10 3-fold increase in exosomal mRNA transcripts, even from cells with low basal levels of exosome secretion. In orthotopic phosphatase and tensin homologue (PTEN)-deficient glioma mouse models, mRNA-containing exosomes restored tumour-suppressor function, enhanced inhibition of tumour growth and increased survival. Cellular nanoporation may enable the use of exosomes as a universal nucleic-acid carrier for applications requiring transcriptional manipulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Compared to exosomes produced endogenously without involving external stimuli, CNP-treated exosomes from cells of the same origin have an increased mRNA encapsulation efficiency of 3–4 folds.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A tumour suppressor gene, like phosphatase and tensin homologue (PTEN), is commonly mutated in wide ranges of GBM, which may be a great candidate for therapeutic intervention27,54.”
From Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system (2025) · cites this paper as [27]
Experimental — accuracy not yet measuredIn the citing paper
“The CNP technology increases the exosome yield and the mRNA amount within the exosomes [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“In addition, this strategy increased mRNA loading in exosomes by 100-fold compared to conventional electroporation methods.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“By modifying the exosome CD47 with these peptides, the targeting ability was improved.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Chemical modification of exosomes was carried out to target GL261 gliomas and U87 glioblastomas.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Moreover, when PTEN mRNA was additionally modified with the CDX peptide, the resulting exosomes exhibited a twofold increase in accumulation in mouse U87 gliomas, leading to prolonged survival.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Similarly, modification of PTEN mRNA with CREKA peptide resulted in a 1.5-fold increase in accumulation in mouse U87 gliomas and improved survival [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Yang et al. modified CD47-derived exosomes by incorporating a glioma targeting peptide at the N terminus. This modification allowed for selective uptake of tumor suppression gene, phosphatase and tensin homolog (PTEN) cargo by glioma cells. As a result, the proliferation of tumor cells was effectively inhibited [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“In Yang et al. research, mouse embryonic fibroblast-derived exosomes were able to deliver PTEN (phosphatase and homologous tensin) mRNA to inhibit mouse glioma growth [49].”
From The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System (2022) · cites this paper as [49]
In the citing paper
“Naturally derived membrane lipids (for example, exosomes and cell membranes) can also be applied for mRNA delivery116,249,250.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [249]
In the citing paper
“However, large-scale production and purification of natural exosomes present significant challenges. Standardization of isolation techniques remains an area of ongoing research, with variations in yield and purity across different methods [36].”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Kowal, J., Arras, G., Colombo, M., Jouve, M., Morath, J. P., Primdal-Bengtson, B., Dingli, F., Loew, D., Tkach, M., & Théry, C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521230113 · Cited by 3,426
Lutz, M. B., Kukutsch, N. A., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,972
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Kamerkar, S., LeBleu, V. S., Sugimoto, H., Yang, S., Ruivo, C. F., Melo, S. A., Lee, J. J., & Kalluri, R. (2017) · Nature · doi:10.1038/nature22341 · Cited by 2,639
Optimized exosome isolation protocol for cell culture supernatant and human plasma
Lobb, R. J., Becker, M., Wen, S., Wong, C. S. F., Wiegmans, A. P., Leimgruber, A., & Möller, A. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27031 · Cited by 1,763
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs
Hergenreider, E., Heydt, S., Tréguer, K., Boettger, T., Horrevoets, A. J. G., Zeiher, A. M., Scheffer, M. P., Frangakis, A. S., Yin, X., Mayr, M., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2441 · Cited by 1,329
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Zhang, L., Zhang, S., Yao, J., Lowery, F. J., Zhang, Q., Huang, W.-C., Li, P., Li, M., Wang, X., Zhang, C., et al. (2015) · Nature · doi:10.1038/nature15376 · Cited by 1,175
Self-citation
Cited by
Sorted by citations
Items 201–300 of 744
Exosomes as Carriers for Drug Delivery in Cancer Therapy
Zeng, W., Wen, Z., Chen, H., & Duan, Y. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03224-y · Cited by 48
RNA nanotherapeutics for hepatocellular carcinoma treatment
Yuan, Y., Sun, W., Xie, J., Zhang, Z., Luo, J., Han, X., Xiong, Y., Yang, Y., & Zhang, Y. (2024) · Theranostics · doi:10.7150/thno.102964 · Cited by 55
Self-citationGather wisdom to overcome barriers: Well-designed nano-drug delivery systems for treating gliomas
Cui, J., Xu, Y., Tu, H., Zhao, H., Wang, H., Di, L., & Wang, R. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.08.013 · Cited by 47
Advances in Therapeutic Applications of Extracellular Vesicles
Zhang, Y., Dou, Y., Liu, Y., Di, M.-Y., Bian, H., Sun, X., & Yang, Q. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s409588 · Cited by 50
Advancing stroke therapy: innovative approaches with stem cell-derived extracellular vesicles
Song, J., Zhou, D., Cui, L., Wu, C., Jia, L., Wang, M., Li, J., Ya, J., Ji, X., & Meng, R. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01752-1 · Cited by 46
Zhiguo, F., Ji, W., Chen, S., Guoyou, Z., Chen, K., Hui, Q., Xu, W., & Zhai, X. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02051-6 · Cited by 47
Advanced micro/nano-electroporation for gene therapy: recent advances and future outlook
Liu, F., Su, R., Jiang, X., Wang, S., Mu, W., & Chang, L. (2024) · Nanoscale · doi:10.1039/d4nr01408a · Cited by 48
Exosomes as drug delivery systems in glioma immunotherapy
Hao, X., Wang, S., Wang, L., Li, J., Li, Y., & Liu, J. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02611-4 · Cited by 49
Liu, Y., Cai, C., Xu, W., Li, B., Wang, L., Peng, Y., Yu, Y., Liu, B., & Zhang, K. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c02914 · Cited by 46
Dong, Z., Yan, S., Liu, B., Hao, Y., Lin, L., Chang, T., Sun, H., Wang, Y., Li, H., Wu, H., et al. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c00199 · Cited by 45
Self-citationLow-intensity ultrasound radiation increases exosome yield for efficient drug delivery
Zhao, Z. X., Qu, L., Shuang, T., Wu, S., Su, Y., Fan, L., Wang, D., Chen, B., & Hao, Q. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101713 · Cited by 45
Du, R., Wang, C., Zhu, L., & Yang, Y. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102236 · Cited by 45
Hao, R., Hu, S., Zhang, H., Chen, X., Yu, Z., Ren, J., Guo, H., & Yang, H. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100527 · Cited by 46
Advances in exosomes utilization for clinical applications in cancer
Batista, I. A., Machado, J. C., & Melo, S. A. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.07.010 · Cited by 49
Cancer Nanomedicines in an Evolving Oncology Landscape
Guo, P., Huang, J., & Moses, M. A. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.08.001 · Cited by 42
Targeted Delivery of Exosomes Armed with Anti-Cancer Therapeutics
Choi, H., Yim, H. Y., Park, C., Ahn, S., Ahn, Y., Lee, A.-R., Yang, H., & Choi, C. (2022) · Membranes · doi:10.3390/membranes12010085 · Cited by 48
Self-citationExosome-based drug delivery systems in cancer therapy
Wang, T., Fu, Y., Sun, S., Huang, C., Yi, Y., Wang, J., Deng, Y., & Wu, M. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.05.022 · Cited by 43
Self-citationEnhancing the Cellular Production of Extracellular Vesicles for Developing Therapeutic Applications
Erwin, N., Serafim, M. F., & He, M. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03420-w · Cited by 41
Engineered mRNA Delivery Systems for Biomedical Applications
Wang, J., Zhu, H., Gan, J., Liang, G., Li, L., & Zhao, Y. (2023) · Advanced Materials · doi:10.1002/adma.202308029 · Cited by 46
Self-citationMassaro, C., Sgueglia, G., Frattolillo, V., Baglio, S. R., Altucci, L., & Dell’Aversana, C. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100980 · Cited by 44
Nucleic acid-based therapy for brain cancer: Challenges and strategies
Zhang, Z., Conniot, J., Amorim, J., Jin, Y., Prasad, R., Yan, X., Fan, K., & Conde, J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.08.014 · Cited by 44
Milk/colostrum exosomes: A nanoplatform advancing delivery of cancer therapeutics
Wallen, M., Aqil, F., Spencer, W. A., & Gupta, R. C. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216141 · Cited by 45
Hua, X., Zhu, Q., Liu, Y., Zhou, S., Huang, P., Li, Q., & Liu, S. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.341160 · Cited by 42
Engineered exosomes for cancer theranostics: Next-generation tumor targeting
Chavda, V. P., Sugandhi, V. V., Pardeshi, C. V., Patil, R., Joshi, M., Patel, B. M., Khadela, A. D., Bezbaruah, R., Bhattacharjee, B., Balar, P. C., et al. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104579 · Cited by 44
Immune cell-derived exosomes as promising tools for cancer therapy
Chen, J., Zhang, G., Wan, Y., Xia, B., Ni, Q., Shan, S., Hu, Z., & Liang, X. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.003 · Cited by 46
Exosomes: Powerful weapon for cancer nano-immunoengineering
Pi, Y., Xia, B.-R., Jin, M., Jin, W., & Lou, G. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114487 · Cited by 42
RNA and Protein Delivery by Cell‐Secreted and Bioengineered Extracellular Vesicles
Wang, B. Z., Luo, L. J., & Vunjak‐Novakovic, G. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101557 · Cited by 45
Physical modulation of mesenchymal stem cell exosomes: A new perspective for regenerative medicine
Wu, D., Zhao, X., Xie, J., Yuan, R., Li, Y., Yang, Q., Cheng, X., Wu, C., Wu, J., & Zhu, N. (2024) · Cell Proliferation · doi:10.1111/cpr.13630 · Cited by 42
Self-citationWan, S., Wang, K., Huang, P., Guo, X., Liu, W., Li, Y., Zhang, J., Li, Z., Song, J., Yang, W., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47710-w · Cited by 43
Extracellular Vesicle‐Based mRNA Therapeutics and Vaccines
Li, Q., Xing, H., Naeem, A., Zhang, K., Zheng, A., Huang, Y., & Lu, M. (2025) · Exploration · doi:10.1002/exp.20240109 · Cited by 44
The role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors
Zheng, Y., Luo, Y., Chen, X., Li, H., Huang, B., Zhou, B., Zhu, L., Kang, X., & Geng, W. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01341-7 · Cited by 41
Gurunathan, S., Kang, M.-H., Jeyaraj, M., & Kim, J. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s305269 · Cited by 42
Recent Progress of Extracellular Vesicle Engineering
Jia, X., Tang, J., Yao, C., & Yang, D. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00868 · Cited by 41
Luo, L., Wu, Z., Wang, Y., & Li, H. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01171-1 · Cited by 41
Self-citationTechniques for increasing the yield of stem cell-derived exosomes: What factors may be involved?
Feng, Z.-Y., Zhang, Q.-Y., Tan, J., & Xie, H.-Q. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-1997-2 · Cited by 40
Bioinspired cellular membrane-derived vesicles for mRNA delivery
Xu, X., Xu, L., Wang, J., Wen, C., Xia, J., Zhang, Y., & Liang, Y. (2024) · Theranostics · doi:10.7150/thno.93755 · Cited by 43
Engineered extracellular vesicles as a next-generation vaccine platform
Lu, M., Xing, H., Zhao, X., Huang, Y., Zheng, A., & Liang, X. (2024) · Matter · doi:10.1016/j.matt.2024.09.012 · Cited by 42
Self-citationEmerging technologies towards extracellular vesicles large-scale production
Huang, J., Chen, H., Li, N., Liu, P., Yang, J., & Zhao, Y. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.06.005 · Cited by 45
Self-citationLi, S., Xu, J., Qian, J., & Gao, X. (2020) · Biomaterials Science · doi:10.1039/d0bm01385d · Cited by 44
Zhou, J., Li, L., Jia, M., Liao, Q., Peng, G., Luo, G., & Zhou, Y. (2022) · Cancer Medicine · doi:10.1002/cam4.5511 · Cited by 43
Versatile biomimetic nanomedicine for treating cancer and inflammation disease
Zhao, Z., Wang, D., & Li, Y. (2023) · Medical Review · doi:10.1515/mr-2022-0046 · Cited by 40
Protein-based delivery systems for RNA delivery
Zhu, H., Luo, H., Chang, R., Yang, Y., Liu, D., Ji, Y. R., Qin, H., Rong, H., & Yin, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.032 · Cited by 40
Immune cell-derived extracellular vesicles for precision therapy of inflammatory-related diseases
Li, S., Li, W., Wu, X., Zhang, B., Liu, L., & Yin, L. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.03.007 · Cited by 41
Engineering exosomes for bone defect repair
Ma, S., Zhang, Y., Li, S., Li, A., Li, Y., & Pei, D. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1091360 · Cited by 38
MAcedo-Pereira, A. H., Martins, C., Lima, J. P., & Sarmento, B. F. C. C. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.04.038 · Cited by 40
Huang, X., Li, A., Xu, P., Yu, Y., Li, S., Hu, L., & Feng, S. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01952-w · Cited by 43
Extracellular Vesicles: A New Star for Gene Drug Delivery
Sun, M., Zhang, H., Liu, J., Chen, J., Cui, Y., Wang, S., Zhang, X., & Yang, Z. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s446224 · Cited by 42
Self-citationChen, S.-Y., Chen, Y.-L., Li, P.-C., Cheng, T.-S., Chu, Y., Shen, Y.-S., Chen, H.-T., Tsai, W., Huang, C., Sieber, M. A., et al. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01019-4 · Cited by 40
Self-citationExosomal ncRNAs in liquid biopsies for lung cancer
Hussain, M. S., Gupta, G., Ghaboura, N., Moglad, E. H. O., Almalki, W. H., Alzarea, S. I., Kazmi, I. A., Ali, H., MacLoughlin, R. J., Löebenberg, R., et al. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119983 · Cited by 39
Interleukin-12 Delivery Strategies and Advances in Tumor Immunotherapy
He, Q., Dong, C., Tan, D., Sun, H., Li, Z., Zheng, Y., Zhang, L., Liu, S., & Zhang, Y. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46100686 · Cited by 38
Ke, C., Hou, H., Li, J., Su, K., Huang, C., Lin, Y., Lu, Z., Du, Z., Tan, W., & Yuan, Z. (2020) · Cancers · doi:10.3390/cancers12051157 · Cited by 38
Functionalized exosome harboring bioactive molecules for cancer therapy
Kim, Y. K., Choi, Y., Nam, G., & Kim, I. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.036 · Cited by 40
Microfluidic approaches for producing lipid-based nanoparticles for drug delivery applications
Piunti, C., & Cimetta, E. (2023) · Biophysics Reviews · doi:10.1063/5.0150345 · Cited by 37
Special delEVery: Extracellular Vesicles as Promising Delivery Platform to the Brain
Pauwels, M. J., Vandendriessche, C., & Vandenbroucke, R. E. (2021) · Biomedicines · doi:10.3390/biomedicines9111734 · Cited by 38
Peng, M., Zhao, Q., Chai, A., Wang, Y., Wang, M., & Du, X. (2024) · Matter · doi:10.1016/j.matt.2024.10.019 · Cited by 38
Self-citationExosomes in Breast Cancer – Mechanisms of Action and Clinical Potential
Liu, T., Hooda, J., Atkinson, J. M., Whiteside, T. L., Oesterreich, S., & Lee, A. V. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0952 · Cited by 38
Self-citationEngineered exosomes as a prospective therapy for diabetic foot ulcers
Guo, L., Xiao, D., Xing, H., Yang, G., & Yang, X. (2024) · Burns & Trauma · doi:10.1093/burnst/tkae023 · Cited by 40
Nanoscale Technologies in Highly Sensitive Diagnosis of Cardiovascular Diseases
Shi, C., Xie, H., Ma, Y., Yang, Z., & Zhang, J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00531 · Cited by 39
Self-citationLiu, Y.-P., Yang, Y.-D., Mou, F.-F., Zhu, J., Li, H., Zhao, T., Zhao, Y., Shao, S.-J., Cui, G.-H., & Guo, H.-D. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7530102 · Cited by 37
Self-citationKurniawati, I., Liu, M.-C. J., Hsieh, C., Do, A. D., & Sung, S. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2709256 · Cited by 39
Biomimetic synthesis and optimization of extracellular vesicles for bone regeneration
Song, X., Xu, L., & Zhang, W. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.057 · Cited by 35
Ulpiano, C., da Silva, C. L., & Monteiro, G. A. (2023) · Biomedicines · doi:10.3390/biomedicines11041231 · Cited by 41
Natural and Bioengineered Extracellular Vesicles in Diagnosis, Monitoring and Treatment of Cancer
Luo, X., McAndrews, K. M., & Kalluri, R. (2025) · ACS Nano · doi:10.1021/acsnano.4c11630 · Cited by 38
Chang, A.-Y., Liu, X., Hong, T., Hua, L., Yang, Z., & Wang, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-63172-8 · Cited by 35
Self-citationExosomes for CRISPR-Cas9 Delivery: The Cutting Edge in Genome Editing
Aslan, C., Zolbanin, N. M., Faraji, F., & Jafari, R. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00932-7 · Cited by 35
Bioengineered mesenchymal stem cell-derived exosomes: emerging strategies for diabetic wound healing
Liu, L., & Liu, D. (2024) · Burns & Trauma · doi:10.1093/burnst/tkae030 · Cited by 35
Mateescu, B., Jones, J. C., Alexander, R. P., Alsop, E. B., An, J. Y., Asghari, M. H., Boomgarden, A. C., Bouchareychas, L., Cayota, A., Chang, H., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104653 · Cited by 35
Self-citationYe, H., Hu, X., Wen, Y., Tu, C., Hornicek, F. J., Duan, Z., & Min, L. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01609-0 · Cited by 35
Zhang, J., Rima, X. Y., Wang, X., Nguyen, L. T. H., Huntoon, K. M., Ma, Y., Palacio, P. L., Nguyen, K. T., Albert, K., Duong‐Thi, M., et al. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12369 · Cited by 30
Self-citationPerspectives in Manipulating EVs for Therapeutic Applications: Focus on Cancer Treatment
Nazimek, K., & Bryniarski, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134623 · Cited by 34
Engineering Extracellular Vesicles to Target Pancreatic Tissue In Vivo
Komuro, H., Kawai‐Harada, Y., Aminova, S., Pascual, N., Malik, A., Contag, C. H., & Harada, M. (2021) · Nanotheranostics · doi:10.7150/ntno.54879 · Cited by 34
Applications of Extracellular Vesicles in Nervous System Disorders: An Overview of Recent Advances
Khan, S. U., Khan, M. I., Khan, M. U., Khan, N. M., BUNGAU, S. G., & Hassan, S. S. U. (2022) · Bioengineering · doi:10.3390/bioengineering10010051 · Cited by 35
Therapeutic Potential of Nucleic Acids when Combined with Extracellular Vesicles
Jurgielewicz, B. J., Stice, S. L., & Yao, Y. (2021) · Aging and Disease · doi:10.14336/ad.2021.0708 · Cited by 32
Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma Treatment
Singh, S., Barik, D., Lawrie, K., Mohapatra, I., Prasad, S., Naqvi, A. R., Singh, A. R., & Singh, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914960 · Cited by 34
Extracellular Vesicles as Drug Delivery System for Cancer Therapy
Wang, J., Yin, B., Lian, J., & Wang, X. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081029 · Cited by 33
Self-citationStem cells for the treatment of glioblastoma: a 20-year perspective
Calinescu, A., Kauss, M. C., Sultan, Z., Al‐Holou, W. N., & O’Shea, S. (2021) · CNS Oncology · doi:10.2217/cns-2020-0026 · Cited by 33
Functional extracellular vesicles aplenty
Zickler, A. M., & Andaloussi, S. E. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0507-z · Cited by 33
An off-the-shelf small extracellular vesicle nanomedicine for tumor targeting therapy
Gong, L., Tian, L., Cui, K., Chen, Y., Liu, B., Li, D., Feng, Y., Yao, S., Yin, Y., Wu, Z., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.013 · Cited by 32
Self-citationStem Cell Therapy against Ischemic Heart Disease
Tsai, I., & Sun, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073778 · Cited by 32
Path towards mRNA delivery for cancer immunotherapy from bench to bedside
Chen, W., Zhu, Y., He, J., & Sun, X. (2023) · Theranostics · doi:10.7150/thno.89247 · Cited by 33
Nanoparticle-Mediated Delivery of STAT3 Inhibitors in the Treatment of Lung Cancer
Feng, Q., & Xiao, K. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122787 · Cited by 30
RNA Nanomedicine: Delivery Strategies and Applications
Byun, J., Wu, Y., Park, J.-W., Kim, J. S., Li, Q., Choi, J., Shin, N., Lan, M., Cai, Y., Lee, J., et al. (2023) · The AAPS Journal · doi:10.1208/s12248-023-00860-z · Cited by 32
Gou, Z., Li, J., Liu, J., & Yang, N. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1378302 · Cited by 34
Jia, S., Liang, R., Chen, J., Liao, S., Lin, J., & Li, W. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00581-x · Cited by 34
Role of aptamer technology in extracellular vesicle biology and therapeutic applications
Chowdhury, R., Eslami, S. S., Pham, C. V., Rai, A., Lin, J., Hou, Y., Greening, D. W., & Duan, W. (2024) · Nanoscale · doi:10.1039/d4nr00207e · Cited by 30
Zhao, R., Deng, X., Tang, Y., Yang, X., Ge, Z., Wang, D., Shen, Y., Jiang, L., Lin, W., Zheng, C., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c13102 · Cited by 30
Patel, N., Chin, D. D., & Chung, E. J. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00621-w · Cited by 30
Improved extracellular vesicle-based mRNA delivery for familial hypercholesterolemia treatment
Yang, Z., Ji, P., Li, Z., Zhang, R., Wei, M., Yang, Y., Yuan, L., Han, Y., & Yang, G. (2023) · Theranostics · doi:10.7150/thno.82873 · Cited by 32
Self-citationNaito, M., Chaya, H., Toh, K., Kim, B. S., Hayashi, K., Fukushima, S., Nagata, T., Yokota, T., Kataoka, K., & Miyata, K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.001 · Cited by 30
Self-citationDNA Nanomaterial‐Empowered Surface Engineering of Extracellular Vesicles
Yao, X., He, D., Wei, P., Niu, Z., Chen, H., Li, L., Fu, P., Wang, Y., Lou, S., Qian, S., et al. (2023) · Advanced Materials · doi:10.1002/adma.202306852 · Cited by 28
Self-citationUltrasound-nanovesicles interplay for theranostics
Liu, J., You, Q., Liang, F., Ma, L., Zhu, L., Wang, C., & Yang, Y. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115176 · Cited by 29
Engineered exosomes for targeted microRNA delivery to reverse liver fibrosis
Zhang, H., Xing, J., Sun, M., Cui, Y., Li, Y., Hu, S., Wang, X., Jiang, H., Zhang, Y., Jiang, X., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123510 · Cited by 34
Self-citationMediratta, K., Diab, M. D., Han, P., Hu, H., & Wang, L. (2025) · Nanomaterials · doi:10.3390/nano15181418 · Cited by 29
Qian, J., Chen, T., Wu, Q., Zhou, L., Zhou, W., Wu, L., Wang, S., Lu, J., Wang, W., Li, D., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.09.015 · Cited by 29
Extracellular Vesicles in Lung Cancer Metastasis and Their Clinical Applications
Saviana, M., Romano, G., Le, P., Acunzo, M., & Nana-Sinkam, P. S. (2021) · Cancers · doi:10.3390/cancers13225633 · Cited by 32
Exosomes and mimics as novel delivery platform for cancer therapy
Yang, F., Wang, M., & Guan, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1001417 · Cited by 30
Lu, L., Zi, H., Zhou, J., Huang, J., Deng, Z., Tang, Z., Li, L., Shi, X., Lo, P., Lovell, J. F., et al. (2023) · Advanced Science · doi:10.1002/advs.202206212 · Cited by 30
Yadav, D., & Malviya, R. (2023) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2023.100163 · Cited by 29
Zhang, H., Shen, Y., Kim, I., Liu, Y., Cai, J., Berman, A. E., Nilsson, K. R., Weintraub, N. L., & Tang, Y. (2023) · Cells · doi:10.3390/cells12060875 · Cited by 28
mRNA-based therapeutic strategies for cancer treatment
Taibi, T., Cheon, S., Perna, F., & Vu, L. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.04.035 · Cited by 31
Metadata
- Authors
- Yang, Z., Shi, J., Xie, J., Wang, Y., Sun, J., Liu, T., Zhao, Y., Zhao, X., Wang, X., Ma, Y., Malkoc, V., Chiang, C., Deng, W., Chen, Y., Fu, Y., Kwak, K. J., Fan, Y., Kang, C., Yin, C., Rhee, J., Bertani, P., Otero, J., Lu, W., Yun, K., Lee, A. S., Jiang, W., Teng, L., Kim, B. Y. S., & Lee, L. J.
- Affiliations
- The Ohio State University (US)
- Jilin University (CN)
- The University of Texas Southwestern Medical Center (US)
- Jinan University (CN)
- Mayo Clinic (US)
- Peking University (CN)
- Institute for Stem Cell Biology and Regenerative Medicine (US)
- Houston Methodist Research Institute (US)
- Shenzhen Bay Laboratory (CN)
- Corresponding author
- Teng, Lesheng
- Kim, Betty Y. S.
- Lee, L. James
- ORCID
- Venue
- Nature Biomedical Engineering
- Published
- 2019-12-16
- Volume
- 4
- Issue
- 1
- Pages
- 69-83
- ISSN
- 2157-846X (ISSN-L)
- PMC
- PMC7080209
- OpenAlex
- W2995128645
- Cited by
- 744
- References
- 49
- Citations by year
- 2026: 81 · 2025: 125 · 2024: 135 · 2023: 128 · 2022: 117 · 2021: 101 · 2020: 56
- FWCI
- 22.67
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-06-15)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (K08CA241070)
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1R01NS104315)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- exosomes, mRNA delivery, electroporation, exosome production, targeting peptides, tumor suppression, nucleic acid carriers, exosome secretion, brain tumors
- MeSH terms
- Animals, Brain Neoplasms, Cells, Cultured, Disease Models, Animal, Glioma, Humans, Mice, Inbred C57BL, RNA, Messenger, Signal Transduction, Drug Delivery Systems, Electroporation, MicroRNAs, Nanotechnology, Exosomes, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
